Our GO enrichment revealed that RPL22L1, INHBA, and CAPZA1 had a significantly higher expression levels in MSI than in MSS, and these genes were also upregulated in CRC cancer tissues compared with their levels in matched normal tissues. The gene discussed is RPL22L1; the disease is colorectal carcinoma.